Nykaa share price: Hot Stocks: Brokerage on Tech Mahindra, Sun Pharma, and Nykaa

Global brokerage firm Macquarie maintained an outperform rating on , Morgan Stanley retained an overweight rating on and BofA upgraded to a buy.

We have collated a list of recommendations from top brokerage firms from ETNow and other sources:

Macquarie on Tech Mahindra: Outperform | Target Rs 1230

Macquarie maintained an outperform rating on Tech Mahindra with a target price of Rs 1230.

Another brokerage firm BofA maintained a buy call on Tech Mahindra with a target of Rs 1180. Deal closures need watching in the forthcoming quarters, the brokerage said.

Margins were largely in-line in Q2. Operating leverage remains key for an uptick in H2, it added.

Morgan Stanley on Sun Pharma: Overweight | Target Rs 1150

Morgan Stanley maintained an overweight rating on Sun Pharma with a target price of Rs 1150. It reported a strong Q2FY23, the brokerage said.

BofA on Nykaa: Buy| Target Rs 1555

BofA upgraded Nykaa to buy with a target price of Rs 1555. The company is well placed to sustain revenue growth and margin improvement, BofA said.

The company reported a strong EBITDA beat. The stock has underperformed recently, but the company has solid fundamentals, and best-in-class execution, the brokerage added.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button